Promyelocytic Leukemia Zinc Finger Protein Regulates Interferon-Mediated Innate Immunity

Immunity

Volumn 30, Issue 6, 2009, Pages 802-816

  Xu, Dakang ^a   Holko, Michelle ^b   Sadler, Anthony J ^a   Scott, Bernadette ^a   Higashiyama, Shigeki ^c   Berkofsky Fessler, Windy ^b   McConnell, Melanie J ^b   Pandolfi, Pier Paolo ^d   Licht, Jonathan D ^b   Williams, Bryan R G ^a  

^a MONASH UNIVERSITY   (Australia)

^b NORTHWESTERN UNIVERSITY   (United States)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

HISTONE DEACETYLASE 1; INTERFERON; PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA ZINC FINGER PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENCEPHALOMYOCARDITIS VIRUS; HUMAN; HUMAN CELL; INFECTION RESISTANCE; INFECTION SENSITIVITY; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA VIRUS INFECTION; SIGNAL TRANSDUCTION; SIMIAN FOAMY VIRUS; VIRUS IMMUNITY;

ALPHAVIRUS INFECTIONS; ANIMALS; CELL LINE, TUMOR; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; IMMUNITY, INNATE; INTERFERON-ALPHA; KILLER CELLS, NATURAL; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEMLIKI FOREST VIRUS; SIGNAL TRANSDUCTION;

EID: 66949167924     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.04.013     Document Type: Article

References (56)

1. Ahmad K.F., Engel C.K., and Prive G.G. Crystal structure of the BTB domain from PLZF. Proc. Natl. Acad. Sci. USA 95 (1998) 12123-12128
2. Bailey T.L., and Elkan C. The value of prior knowledge in discovering motifs with MEME. Proc. Int. Conf. Intell. Syst. Mol. Biol. 3 (1995) 21-29
3. Ball H.J., Melnick A., Shaknovich R., Kohanski R.A., and Licht J.D. The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase. Nucleic Acids Res. 27 (1999) 4106-4113
4. Barna M., Hawe N., Niswander L., and Pandolfi P.P. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 25 (2000) 166-172
5. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu. Rev. Immunol. 17 (1999) 189-220
6. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R., and Stark G.R. Interferons at age 50: Past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6 (2007) 975-990
7. Campbell C.E., Kuriyan N.P., Rackley R.R., Caulfield M.J., Tubbs R., Finke J., and Williams B.R. Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma. Int. J. Cancer 78 (1998) 182-188
8. Cao X., Cai S.F., Fehniger T.A., Song J., Collins L.I., Piwnica-Worms D.R., and Ley T.J. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27 (2007) 635-646
9. Chang H.M., Paulson M., Holko M., Rice C.M., Williams B.R., Marie I., and Levy D.E. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc. Natl. Acad. Sci. USA 101 (2004) 9578-9583
10. Chauchereau A., Mathieu M., de Saintignon J., Ferreira R., Pritchard L.L., Mishal Z., Dejean A., and Harel-Bellan A. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF. Oncogene 23 (2004) 8777-8784
11. David G., Alland L., Hong S.H., Wong C.W., DePinho R.A., and Dejean A. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16 (1998) 2549-2556
12. Day P.M., Baker C.C., Lowy D.R., and Schiller J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. USA 101 (2004) 14252-14257
13. Dong S., Zhu J., Reid A., Strutt P., Guidez F., Zhong H.J., Wang Z.Y., Licht J.D., Waxman S., Chomienne C., et al. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc. Natl. Acad. Sci. USA 93 (1996) 3624-3629
14. Fehniger T.A., Cai S.F., Cao X., Bredemeyer A.J., Presti R.M., French A.R., and Ley T.J. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26 (2007) 798-811
15. Fenner J.E., Starr R., Cornish A.L., Zhang J.G., Metcalf D., Schreiber R.D., Sheehan K., Hilton D.J., Alexander W.S., and Hertzog P.J. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat. Immunol. 7 (2006) 33-39
16. Frevel M.A., Bakheet T., Silva A.M., Hissong J.G., Khabar K.S., and Williams B.R. p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol. Cell. Biol. 23 (2003) 425-436
17. Goh K.C., Haque S.J., and Williams B.R. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 18 (1999) 5601-5608
18. Goodbourn S., Didcock L., and Randall R.E. Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81 (2000) 2341-2364
19. Guidez F., Howell L., Isalan M., Cebrat M., Alani R.M., Ivins S., Hormaeche I., McConnell M.J., Pierce S., Cole P.A., et al. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 25 (2005) 5552-5566
20. Handwerger K.E., and Gall J.G. Subnuclear organelles: New insights into form and function. Trends Cell Biol. 16 (2006) 19-26
21. Haque S.J., and Williams B.R. Signal transduction in the interferon system. Semin. Oncol. 25 (1998) 14-22
22. Haverty P.M., Frith M.C., and Weng Z. CARRIE web service: Automated transcriptional regulatory network inference and interactive analysis. Nucleic Acids Res. 32 (2004) w213-w216
23. Holko M., and Williams B.R. Functional annotation of IFN-alpha-stimulated gene expression profiles from sensitive and resistant renal cell carcinoma cell lines. J. Interferon Cytokine Res. 26 (2006) 534-547
24. Hong S.H., David G., Wong C.W., Dejean A., and Privalsky M.L. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94 (1997) 9028-9033
25. Isaacs A., Lindenmann J., and Valentine R.C. Virus interference. II. Some properties of interferon. Proc. R. Soc. Lond. B. Biol. Sci. 147 (1957) 268-273
26. Koken M.H., Reid A., Quignon F., Chelbi-Alix M.K., Davies J.M., Kabarowski J.H., Zhu J., Dong S., Chen S.J., Chen Z., et al. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc. Natl. Acad. Sci. USA 94 (1997) 10255-10260
27. Kovalovsky D., Uche O.U., Eladad S., Hobbs R.M., Yi W., Alonzo E., Chua K., Eidson M., Kim H.J., Im J.S., et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9 (2008) 1055-1064
28. Labbaye C., Quaranta M.T., Pagliuca A., Militi S., Licht J.D., Testa U., and Peschle C. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene 21 (2002) 6669-6679
29. Lecoeur H., Fevrier M., Garcia S., Riviere Y., and Gougeon M.L. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods 253 (2001) 177-187
30. Lee S.H., Miyagi T., and Biron C.A. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 28 (2007) 252-259
31. McConnell M.J., Chevallier N., Berkofsky-Fessler W., Giltnane J.M., Malani R.B., Staudt L.M., and Licht J.D. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol. Cell. Biol. 23 (2003) 9375-9388
32. McLoughlin P., Ehler E., Carlile G., Licht J.D., and Schäfer B.W. The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein. J. Biol. Chem. 277 (2002) 37045-37053
33. Melnick A., Ahmad K.F., Arai S., Polinger A., Ball H.J., Borden K.L., Carlile G.W., Prive G.G., and Licht J.D. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol. Cell. Biol. 20 (2000) 6550-6567
34. Melnick A.M., Westendorf J.J., Polinger A., Carlile G.W., Arai S., Ball H.J., Lutterbach B., Hiebert S.W., and Licht J.D. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 20 (2000) 2075-2086
35. Pestka S., Langer J.A., Zoon K.C., and Samuel C.E. Interferons and their actions. Annu. Rev. Biochem. 56 (1987) 727-777
36. Qiu Y., Zhao Y., Becker M., John S., Parekh B.S., Huang S., Hendarwanto A., Martinez E.D., Chen Y., Lu H., et al. HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol. Cell 22 (2006) 669-679
37. Regad T., and Chelbi-Alix M.K. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20 (2001) 7274-7286
38. Sadler A.J., and Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8 (2008) 559-568
39. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., Lantz O., and Bendelac A. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29 (2008) 391-403
40. Senbonmatsu T., Saito T., Landon E.J., Watanabe O., Price E.J., Roberts R.L., Imboden H., Fitzgerald T.G., Gaffney F.A., and Inagami T. A novel angiotensin II type 2 receptor signaling pathway: Possible role in cardiac hypertrophy. EMBO J. 22 (2003) 6471-6482
41. Severa M., Coccia E.M., and Fitzgerald K.A. Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J. Biol. Chem. 281 (2006) 26188-26195
42. Shey M.R., and Ballas Z.K. Assessment of natural killer (NK) and NKT cells in murine spleens and livers. Methods Mol. Biol. 447 (2008) 259-276
43. Silverman R.H. Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81 (2007) 12720-12729
44. Sledz C.A., and Williams B.R. RNA interference and double-stranded-RNA-activated pathways. Biochem. Soc. Trans. 32 (2004) 952-956
45. Stadler M., Chelbi-Alix M.K., Koken M.H., Venturini L., Lee C., Saib A., Quignon F., Pelicano L., Guillemin M.C., Schindler C., et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11 (1995) 2565-2573
46. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
47. Stormo G.D. DNA binding sites: Representation and discovery. Bioinformatics 16 (2000) 16-23
48. Sweet M.J., Leung B.P., Kang D., Sogaard M., Schulz K., Trajkovic V., Campbell C.C., Xu D., and Liew F.Y. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 166 (2001) 6633-6639
49. Tenoever B.R., Ng S.L., Chua M.A., McWhirter S.M., Garcia-Sastre A., and Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315 (2007) 1274-1278
50. Terenzi F., White C., Pal S., Williams B.R., and Sen G.C. Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J. Virol. 81 (2007) 8656-8665
51. Thapa M., Welner R.S., Pelayo R., and Carr D.J. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J. Immunol. 180 (2008) 1098-1106
52. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98 (2001) 5116-5121
53. van Boxel-Dezaire A.H., Rani M.R., and Stark G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25 (2006) 361-372
54. Walsh K.B., Edwards R.A., Romero K.M., Kotlajich M.V., Stohlman S.A., and Lane T.E. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease. J. Immunol. 179 (2007) 1155-1165
55. Zimmerer J.M., Lesinski G.B., Radmacher M.D., Ruppert A., and Carson III W.E. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha. Cancer Immunol. Immunother. 56 (2007) 1845-1852
56. Zupkovitz G., Tischler J., Posch M., Sadzak I., Ramsauer K., Egger G., Grausenburger R., Schweifer N., Chiocca S., Decker T., and Seiser C. Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol. Cell. Biol. 26 (2006) 7913-7928